company background image
TTB

Total BrainASX:TTB Stock Report

Market Cap

AU$23.3m

7D

-5.4%

1Y

-50.7%

Updated

26 Oct, 2021

Data

Company Financials +
TTB fundamental analysis
Snowflake Score
Valuation3/6
Future Growth6/6
Past Performance0/6
Financial Health4/6
Dividends0/6

TTB Overview

Total Brain Limited, together with its subsidiaries, develops and sells brain health products in the United States and Australia.

Price History & Performance

Summary of all time highs, changes and price drops for Total Brain
Historical stock prices
Current Share PriceAU$0.17
52 Week HighAU$0.17
52 Week LowAU$0.51
Beta1.07
1 Month Change-29.29%
3 Month Change-31.37%
1 Year Change-50.70%
3 Year Change-52.70%
5 Year Change-81.58%
Change since IPO-94.17%

Recent News & Updates

Shareholder Returns

TTBAU HealthcareAU Market
7D-5.4%3.0%0.8%
1Y-50.7%17.4%24.4%

Return vs Industry: TTB underperformed the Australian Healthcare industry which returned 17.4% over the past year.

Return vs Market: TTB underperformed the Australian Market which returned 24.4% over the past year.

Price Volatility

Is TTB's price volatile compared to industry and market?
TTB volatility
TTB Beta1.07
Industry Beta0.61
Market Beta1

Stable Share Price: TTB is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: TTB's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/aLouis Gagnonhttps://www.totalbrain.com

Total Brain Limited, together with its subsidiaries, develops and sells brain health products in the United States and Australia. It offers Total Brain, a neuroscience-based mental health and brain performance app. The company was formerly known as Brain Resource Limited and changed its name to Total Brain Limited in December 2018.

Total Brain Fundamentals Summary

How do Total Brain's earnings and revenue compare to its market cap?
TTB fundamental statistics
Market CapAU$23.34m
Earnings (TTM)-AU$8.32m
Revenue (TTM)AU$3.69m

6.3x

P/S Ratio

-2.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TTB income statement (TTM)
RevenueAU$3.69m
Cost of RevenueAU$8.88m
Gross Profit-AU$5.18m
ExpensesAU$3.13m
Earnings-AU$8.32m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.062
Gross Margin-140.34%
Net Profit Margin-225.13%
Debt/Equity Ratio23.7%

How did TTB perform over the long term?

See historical performance and comparison

Valuation

Is Total Brain undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: TTB (A$0.18) is trading below our estimate of fair value (A$3.82)

Significantly Below Fair Value: TTB is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: TTB is unprofitable, so we can't compare its PE Ratio to the Australian Healthcare industry average.

PE vs Market: TTB is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TTB's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TTB is good value based on its PB Ratio (1.3x) compared to the AU Healthcare industry average (2.2x).


Future Growth

How is Total Brain forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

88.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TTB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: TTB is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: TTB's is expected to become profitable in the next 3 years.

Revenue vs Market: TTB's revenue (55% per year) is forecast to grow faster than the Australian market (5.3% per year).

High Growth Revenue: TTB's revenue (55% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: TTB's Return on Equity is forecast to be high in 3 years time (20.6%)


Past Performance

How has Total Brain performed over the past 5 years?

5.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: TTB is currently unprofitable.

Growing Profit Margin: TTB is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: TTB is unprofitable, but has reduced losses over the past 5 years at a rate of 5.5% per year.

Accelerating Growth: Unable to compare TTB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TTB is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (61.3%).


Return on Equity

High ROE: TTB has a negative Return on Equity (-46.25%), as it is currently unprofitable.


Financial Health

How is Total Brain's financial position?


Financial Position Analysis

Short Term Liabilities: TTB's short term assets (A$6.8M) exceed its short term liabilities (A$6.1M).

Long Term Liabilities: TTB has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: TTB's debt to equity ratio (23.7%) is considered satisfactory.

Reducing Debt: TTB's debt to equity ratio has reduced from 31.6% to 23.7% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TTB has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if TTB has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Total Brain current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate TTB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate TTB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if TTB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TTB's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TTB's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.7yrs

Average management tenure


CEO

Louis Gagnon

4.42yrs

Tenure

AU$538,929

Compensation

Mr. Louis Gagnon has been Chief Executive Officer of Total Brain Limited (formerly known as Brain Resource Limited) since May 22, 2017 and has been its Managing Director since December 22, 2017. Mr. Gagnon...


CEO Compensation Analysis

Compensation vs Market: Louis's total compensation ($USD403.99K) is above average for companies of similar size in the Australian market ($USD301.38K).

Compensation vs Earnings: Louis's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: TTB's management team is considered experienced (3.7 years average tenure).


Board Members

Experienced Board: TTB's board of directors are considered experienced (3.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: TTB insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.2%.


Top Shareholders

Company Information

Total Brain Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Total Brain Limited
  • Ticker: TTB
  • Exchange: ASX
  • Founded: 2000
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: AU$23.343m
  • Shares outstanding: 133.39m
  • Website: https://www.totalbrain.com

Number of Employees


Location

  • Total Brain Limited
  • 15 Belvoir Street
  • Surry Hills
  • New South Wales
  • 2010
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/26 07:02
End of Day Share Price2021/10/26 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.